FDA weight loss drug safety: No increased suicide risk found
The FDA weight loss drug safety review found no evidence of increased suicidal behavior, leading to removal of related warnings and emphasizing the importance
Ozempic appetite and eating: Experts explain hunger
Ozempic appetite and eating highlight how appetite suppression from GLP-1 receptor agonists may not fully alter social dining behaviors influenced by
Novo Nordisk stock decline as weight-loss drug craze fades
The Novo Nordisk stock decline in 2023 has caused stock prices to retreat amid volatility and changing market conditions, prompting investors to reassess its